ArticlePatient preference and adherence2025
Initial Management Strategies for Oral Mucosal Lesions Among Local Pharmacists in Saudi Arabia: A Cross-Sectional Study.
Article in Patient preference and adherence, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Hyaluronic Acid-Based Gels and Biomaterial Systems for Oral Wound Healing: Design and Clinical Translation.Gels (Basel, Switzerland) · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Purpose: Pharmacists may be an initial point-of-contact for patients with oral mucosal lesions. The purpose of this study was to investigate the proficiency of pharmacists in recognizing and managing oral mucosal lesions to help formulate educational recommendations for improvements in pharmacist-led patient care. Methods: Pharmacists in community pharmacies in Jeddah, Saudi Arabia, completed structured interviews that included five images of oral mucosal lesions (Herpes labialis, Lichen planus, Traumatic lip ulcer, Candidiasis, and Squamous cell carcinoma) with short clinical scenarios. Pharmacists were asked how they would manage the patients and about their knowledge of oral cancer. Results: One hundred and forty pharmacists participated. Herpes labialis was correctly identified by 81.6% of pharmacists, followed by traumatic ulcers (65.2%). No pharmacist correctly identified lichen planus, while squamous cell carcinoma was correctly identified in 14.9% of cases. Lichen planus (51.8%) was most commonly referred to specialist services, followed by squamous cell carcinoma (45.4%). Most pharmacists prescribed over-the-counter medications to treat the lesions. Most pharmacists recommended appropriate antiviral treatment for herpes labialis (70.2%) and wound care for traumatic lip ulcers (71.6%). However, 68.1% referred patients to healthcare professionals. Around 75.2% of pharmacists opted to refer to healthcare providers in cancer patients. Conclusion: While pharmacists could play a significant role in providing accurate and timely medical or pharmacological advice to patients with oral mucosal lesions, further education and training are required to improve knowledge to inform decision-making.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.